An industry leader in personal genetics.

23andMe study discovers two novel gentic associations with Parkinson’s Leading personal genetics company analyzed largest single Parkinson’s GWAS cohort to time and proves achievement of using Web-based options for research enrollment and data collection to yield new scientific insights into etiology of Parkinson’s diseaseToday 23andMe, an industry leader in personal genetics, announced the discovery of two significant, novel genetic associations with Parkinson’s disease and provided fresh evidence that there surely is a considerable genetic component remaining to be found out for Parkinson’s . Web-structured genome-wide association study identifies two novel loci and a substantial genetic element for Parkinson’s disease was published on the web today in PLoS Genetics.

This trans-company endeavor links the NHLBI-supported TACTIC program with Department of Defense clinical trauma study centers in a distinctive initiative that integrates laboratory, early and clinical translational, hypothesis-driven analysis by leading investigators in the united states and enable the basic science investigative units to explore clinical specimens attained from the DoD centers.. $23.8M NIH grant supports multi-center, multidisciplinary study about deadly bleeding syndrome A fresh five-year, $23.8 million National Institutes of Health grant will support a multi-center, multidisciplinary study on a deadly bleeding syndrome – called coagulopathy – that occurs without warning in some trauma individuals.